Biosimilar Regulatory Update

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

TARIS BioMedical, Inc. - Product Pipeline Review - 2014

TARIS BioMedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • September 2014
  • 24 pages

TARIS BioMedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘TARIS BioMedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TARIS BioMedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the ...

Industries: Biopharmaceutical | Countries: World

Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 111 pages

Growth Hormone Deficiency - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H2 2014', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Biopharmaceutical | Countries: United States, World

Global Markets for Bioengineered Protein Drugs

Global Markets for Bioengineered Protein Drugs

  • $ 6 650
  • Industry report
  • by BCC Research
  • August 2014
  • 189 pages

This BCC Research report explores the present and future strategies within the bioengineered protein drugs market. It analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. Revenues are broken down by region. CAGR projections are ...

Industries: Biopharmaceutical | Countries: World

Boston Biomedical, Inc. - Product Pipeline Review - 2014

Boston Biomedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • July 2014
  • 24 pages

Boston Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Boston Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the Boston Biomedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on ...

Industries: Biopharmaceutical | Countries: World

Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 17 pages

Summary Eiger BioPharmaceuticals, Inc. (Eiger) is a biopharmaceutical company. The company discovers and develops new antiviral agents to treat hepatitis virus infection. Its product candidates include EBP921, EBP994, and Hepatititis Delta Virus (HDV) Replication and Prenylation. The company's HDV large ...

Industries: Biopharmaceutical | Countries: United States, World

Boston Biomedical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Boston Biomedical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 19 pages

Summary Boston Biomedical, Inc. (Boston Biomedical) is a biotechnology company. The company develops novel therapeutics to treat cancer. It has developed oncology drug research, such as drug discovery, crystallography, medicinal chemistry, preclinical development, pharmacology, pharmaceutical development, ...

Industries: Biopharmaceutical | Countries: United States, North America, World

Epitomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Epitomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 21 pages

Summary Epitomics, Inc. (Epitomics) is a biotechnology company, based in the US. The company designs, develops and distributes monoclonal antibody technology (RabMab). Its antibody products are secondary antibodies, rabbit monoclonal abs, phospho specific abs, mouse validated ihc abs, flow cytometry ...

Industries: Biopharmaceutical | Countries: Denmark, United States, World, Europe

AnaptysBio, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AnaptysBio, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 27 pages

Summary AnaptysBio, Inc. (AnaptysBio) is a biotechnology company. The company develops therapeutic antibody products. It uses somatic hypermutation for antibody discovery and optimization. AnaptysBio is developing a pipeline of novel therapeutic antibody candidates, which include differentiated programs ...

Industries: Biopharmaceutical | Countries: United States, World

Pfenex Inc. - Product Pipeline Review - 2014

Pfenex Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • July 2014
  • 40 pages

Pfenex Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental ...

Industries: Biopharmaceutical | Countries: World

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • July 2014
  • 34 pages

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Genervon Biopharmaceuticals, LLC's pharmaceutical research and development focus. This report provides ...

Industries: Biopharmaceutical | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.